Drospirenone
Drospirenone is the progestin in Yaz, a combined oral contraceptive used for Contraception and for treating Premenstrual Dysphoric Disorder. Yaz pairs 3 mg drospirenone with 0.02 mg ethinylestradiol.
Key points
- Smoking increases the risk of serious cardiovascular events from combined oral contraceptives; women over 35 who smoke should not use Yaz.
- Drospirenone’s antimineralocorticoid activity carries a risk of high potassium levels, so women on medicines that raise potassium should have levels checked during the first cycle.
- The effectiveness of Yaz for PMDD has not been evaluated beyond three menstrual cycles.
How does Drospirenone work?
Drospirenone is a spironolactone analogue with antiandrogenic and mild antimineralocorticoid properties. In Yaz, it works alongside ethinylestradiol to suppress ovulation, the primary way combined oral contraceptives prevent pregnancy. Changes in the endometrium contribute a second contraceptive effect. The same progestin appears in Yasmin, listed under Women’s Health.
